Compare LKQ & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LKQ | ALGN |
|---|---|---|
| Founded | 1998 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Motor Vehicles | Industrial Specialties |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 10.2B |
| IPO Year | 2003 | N/A |
| Metric | LKQ | ALGN |
|---|---|---|
| Price | $30.96 | $165.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 14 |
| Target Price | $44.33 | ★ $188.92 |
| AVG Volume (30 Days) | ★ 2.9M | 1.6M |
| Earning Date | 10-30-2025 | 10-29-2025 |
| Dividend Yield | ★ 3.87% | N/A |
| EPS Growth | ★ 0.63 | N/A |
| EPS | 2.69 | ★ 5.16 |
| Revenue | ★ $14,097,000,000.00 | $3,982,622,000.00 |
| Revenue This Year | N/A | $2.58 |
| Revenue Next Year | $1.95 | $3.41 |
| P/E Ratio | ★ $11.50 | $32.05 |
| Revenue Growth | N/A | ★ 0.56 |
| 52 Week Low | $28.13 | $122.00 |
| 52 Week High | $44.82 | $241.29 |
| Indicator | LKQ | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 78.33 |
| Support Level | $28.13 | $144.00 |
| Resistance Level | $29.78 | $166.61 |
| Average True Range (ATR) | 0.79 | 4.66 |
| MACD | 0.20 | 1.60 |
| Stochastic Oscillator | 84.70 | 94.04 |
Since forming in 1998 to consolidate the auto salvage business in the United States, LKQ has developed into a leading distributor of aftermarket and recycled auto parts with around 1,500 facilities across North America and Europe. The company primarily sells into the professional channel and offers an assortment of collision and mechanical parts to both body shops and mechanical repair shops. It also continues to operate more than 70 LKQ pick-your-part junkyards. Separate from the self-service business, LKQ usually purchases around 250,000 salvage vehicles annually that are used to extract vehicle parts for resale.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.